The Journal of Experimental Medicine
for flow cytometry > invitrogen
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online
doi:10.1084/jem.20072076
The Journal of Experimental Medicine, Vol. 205, No. 9, 2111-2124
The Rockefeller University Press, 0022-1007 $30.00
© Das et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 3924K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Das, A.
Right arrow Articles by Maini, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Das, A.
Right arrow Articles by Maini, M. K.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrowRelated In this Issue article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection

Abhishek Das1, Matthew Hoare4, Nathan Davies2, A. Ross Lopes1, Claire Dunn1, Patrick T.F. Kennedy2, Graeme Alexander4, Helene Finney5, Alistair Lawson5, Fiona J. Plunkett1, Antonio Bertoletti2,6, Arne N. Akbar1, and Mala K. Maini1,3

1 Division of Infection and Immunity, 2 Institute of Hepatology, 3 Camden Primary Care Trust and Centre for Sexual Health and HIV, University College London, London W1T 4JF, England, UK
4 Department of Medicine, Addenbrooke's Hospital Cambridge, Cambridge CB2 2QQ, England, UK
5 UCB Celltech, Berkshire SL1 4EN, England, UK
6 Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, Singapore 138632

CORRESPONDENCE Mala K. Maini: m.maini{at}ucl.ac.uk

The inflamed liver in chronic hepatitis B virus (HBV) infection (CHB) is characterized by a large influx of non–virus-specific CD8 T cells. Little is known about the functional capacity of these lymphocytes, which could provide insights into mechanisms of failure of viral control and liver damage in this setting. We compared the effector function of total circulating and intrahepatic CD8 T cells in CHB patients and healthy donors. We demonstrated that CD8 T cells from CHB patients, regardless of their antigen specificity, were impaired in their ability to produce interleukin-2 and proliferate upon TCR-dependent stimulation. In contrast, these CD8 T cells had preserved production of the proinflammatory cytokines interferon-{gamma} and tumor necrosis factor-{alpha}. This aberrant functional profile was partially attributable to down-regulation of the proximal T cell receptor signaling molecule CD3{zeta}, and could be corrected in vitro by transfection of CD3{zeta} or replenishment of the amino acid arginine required for its expression. We provide evidence for depletion of arginine in the inflamed hepatic microenvironment as a potential mechanism for these defects in global CD8 T cell signaling and function. These data imply that polarized CD8 T cells within the HBV-infected liver may impede proliferative antiviral effector function, while contributing to the proinflammatory cytokine environment.


Abbreviations used: ALT, alanine aminotransferase; CHB, chronic HBV infection; HBV, hepatitis B virus; MDSC, myeloid-derived suppressor cell.

© 2008 Das et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related In this Issue article

Arginine reverses T cell defects
Hema Bashyam
J. Exp. Med. 2008 205: 1944. [Full Text] [PDF]





  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS